Parent L J, Cairns T M, Albert J A, Wilson C B, Wills J W, Craven R C
Department of Medicine, The Pennsylvania State University College of Medicine, M. S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.
J Virol. 2000 Jan;74(1):164-72. doi: 10.1128/jvi.74.1.164-172.2000.
The retrovirus matrix (MA) sequence of the Gag polyprotein has been shown to contain functions required for membrane targeting and binding during particle assembly and budding. Additional functions for MA have been proposed based on the existence of MA mutants in Rous sarcoma virus (RSV), murine leukemia virus, human immunodeficiency virus type 1, and human T-cell leukemia virus type 1 that lack infectivity even though they release particles of normal composition. Here we describe an RSV MA mutant with a surprising and previously unreported phenotype. In the mutant known as Myr1E, the small membrane-binding domain of the Src oncoprotein has been added as an N-terminal extension of Gag. While Myr1E is not infectious, full infectivity can be reestablished by a single amino acid substitution in the Src sequence (G2E), which eliminates the addition of myristic acid and the membrane-binding capacity of this foreign sequence. The presence of myristic acid at the N terminus of the Myr1E Gag protein does not explain its replication defect, because other myristylated derivatives of RSV Gag are fully infectious (e.g., Myr2 [C. R. Erdie and J. W. Wills, J. Virol. 64:5204-5208, 1990]). Biochemical analyses of Myr1E particles reveal that they contain wild-type levels of the Gag cleavage products, Env glycoproteins, and reverse transcriptase activity when measured on an exogenous template. Genomic RNA incorporation appears to be mildly reduced compared to the wild-type level. Unexpectedly, RNA isolated from Myr1E particles is monomeric when analyzed on nondenaturing Northern blots. Importantly, the insertional mutation does not lie within previously identified dimer linkage sites. In spite of the dimerization defect, the genomic RNA from Myr1E particles serves efficiently as a template for reverse transcription as measured by an endogenous reverse transcriptase assay. In marked contrast, after infection of avian cells, the products of reverse transcription are nearly undetectable. These findings might be explained either by the loss of a normal function of MA needed in the formation or stabilization of RNA dimers or by the interference in such events by the mutant MA molecules. It is possible that Myr1E viruses package a single copy of viral RNA.
逆转录病毒Gag多聚蛋白的基质(MA)序列已被证明在病毒颗粒组装和出芽过程中包含膜靶向和结合所需的功能。基于劳氏肉瘤病毒(RSV)、鼠白血病病毒、人类免疫缺陷病毒1型和人类T细胞白血病病毒1型中存在MA突变体,尽管它们释放的颗粒成分正常,但缺乏感染性,人们提出了MA的其他功能。在此,我们描述了一种具有令人惊讶且此前未报道表型的RSV MA突变体。在名为Myr1E的突变体中,Src癌蛋白的小膜结合结构域已作为Gag的N端延伸添加。虽然Myr1E没有感染性,但通过Src序列中的单个氨基酸取代(G2E)可以恢复完全感染性,这消除了肉豆蔻酸的添加以及该外源序列的膜结合能力。Myr1E Gag蛋白N端存在肉豆蔻酸并不能解释其复制缺陷,因为RSV Gag的其他肉豆蔻酰化衍生物具有完全感染性(例如,Myr2 [C. R. Erdie和J. W. Wills,J. Virol. 64:5204 - 5208,1990])。对Myr1E颗粒的生化分析表明,当在外源模板上进行测量时,它们含有野生型水平的Gag裂解产物、Env糖蛋白和逆转录酶活性。与野生型水平相比,基因组RNA的掺入似乎略有减少。出乎意料的是,在非变性Northern印迹分析中,从Myr1E颗粒中分离的RNA是单体形式。重要的是,插入突变并不位于先前确定的二聚体连接位点内。尽管存在二聚化缺陷,但通过内源性逆转录酶测定法测量,来自Myr1E颗粒的基因组RNA可有效地作为逆转录模板。与之形成鲜明对比的是,在感染禽细胞后,逆转录产物几乎无法检测到。这些发现可能是由于在RNA二聚体形成或稳定过程中MA正常功能的丧失,或者是由于突变的MA分子对这些事件的干扰。有可能Myr1E病毒包装了单拷贝的病毒RNA。